New capsule aims to ease IBS-D symptoms without drugs

NCT ID NCT06681012

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether Gelsectan, a capsule made from plant-based ingredients, can reduce abdominal pain and improve stool consistency in people with diarrhea-predominant irritable bowel syndrome (IBS-D). About 330 adults will take either Gelsectan or a placebo twice daily for two months. The goal is to see if this device can offer a safe, non-drug way to manage symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Gelsectan (a medical device containing xyloglucan, pea protein, grape seed extract, and xylo-oligosaccharides)
What this could lead to
If it works, this could provide a new, non-drug option to help manage IBS-D symptoms like abdominal pain and diarrhea, improving quality of life.
What could go wrong
This is a mid-stage study, so results may not confirm earlier findings. The effect may be modest, and not everyone will benefit. As a medical device, it is generally considered low-risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME (IBS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AOU Federico II di Napoli

    RECRUITING

    Naples, 80131, Italy

  • Azienda Ospedale Università Padova

    RECRUITING

    Padova, 35128, Italy

  • Azienda Ospedaliero Universitaria Pisana (AOUP)

    RECRUITING

    Pisa, 56124, Italy

  • CHU de Rouen

    RECRUITING

    Rouen, 76000, France

  • Fondazione IRCCS Policlinico San Matteo

    RECRUITING

    Pavia, 27100, Italy

  • Hospital Universitario Ramón y Cajal

    RECRUITING

    Madrid, 28034, Spain

  • Hospital Universitario Vall d´Hebron

    RECRUITING

    Barcelona, 08035, Spain

  • Hôpital Avicenne

    RECRUITING

    Bobigny, 93000, France

  • IRCCS Azienda Ospedaliero Universitaria di Bologna Policlinico Sant'Orsola

    RECRUITING

    Bologna, BO, 40138, Italy

  • IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation

    RECRUITING

    Milan, 20122, Italy

  • S. Andrea University Hospital

    RECRUITING

    Roma, 00189, Italy

  • University Hospitals Leuven (UZ Leuven)

    RECRUITING

    Leuven, 3000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.